EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Improving HPV Vaccine Coverage in Tennessee: Addressing Barriers and Expanding Access for Mid-Adults

Donald J Alcendor, Patricia Matthews-Juarez, Mohammad Tabatabai iD, Derek Wilus iD, James E K Hildreth, Paul D Juarez iD

Pathogens · 2025

DOI: 10.3390/pathogens14040311 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, 2025. Verfasst von Donald J Alcendor und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for AIDS Health Disparities Research, Department of Microbiology, Immunology, and Physiology, School of Medicine, Meharry Medical College, 100…. Hauptthemen laut MEDLINE: Papillomavirus Vaccines, Papillomavirus Infections, Vaccination Coverage, Health Services Accessibility. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, CEO Roundtable on Cancer, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human papillomavirus (HPV) is the most common sexually transmitted infection in the US and the world. Infection with high-risk oncogenic HPV strains has been shown to induce cellular transformation leading to anogenital and oropharyngeal cancers. The HPV vaccine, first developed in 2006 for females aged 9–26 years, has been demonstrated to be safe and effective in preventing 90% of all HPV-associated cancers. However, vaccine hesitancy, misinformation, and barriers to vaccine access has resulted in suboptimal vaccination rates among adolescent populations, especially in rural communities in the South. HPV vaccine coverage in Tennessee is currently below the national average and below the Healthy People 2030 goal of an 80% vaccination rate for individuals 13–17 years old based on recommendation guidelines for up-to-date HPV vaccination status as of 2022. HPV vaccination rates for Tennesseans with private insurance in 2022 were 68% and 38% for those that were uninsured. Up-to-date HPV vaccination rates in 2022 for Tennesseans were 58% and 46% for those living in urban communities and rural communities, respectively. Overall, HPV-associated cancers rates are higher in Tennessee, at 12.9/100,000 compared to the overall rate in the US of 11.8/100,000 persons in 2022. Interventions to improve HPV vaccine awareness, education, and access could improve vaccine confidence and uptake, especially among rural and uninsured populations in Tennessee. Most recently, the Advisory Committee on Immunization Practices (ACIP) expanded recommendations for HPV vaccinations for some individuals aged 27–45 years who were not vaccinated at a younger age, with shared clinical decision making. Further research is needed to evaluate the impact of this recommendation on HPV vaccination rates and cancer prevention in Tennessee.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus VaccinesPapillomavirus InfectionsVaccination CoverageHealth Services AccessibilityHumansTennesseeFemaleAdultAdolescentYoung AdultVaccinationMiddle AgedMaleRural Population

Stichwörter der Autor:innen

HPVTennesseehuman papilloma virusmid-adultsvaccination ratevaccinevaccine hesitancy

Substanzen

Papillomavirus Vaccines

Autor:innen und Institutionen

  • Center for AIDS Health Disparities Research, Department of Microbiology, Immunology, and Physiology, School of Medicine, Meharry Medical College, 1005 Dr. D.B. Todd Jr. Blvd., Nashville, TN 37208-3599, USA.
  • Department of Family & Community Medicine, Meharry Medical College, 1005 D.B. Todd Jr. Blvd., Nashville, TN 37208-3501, USA.
  • Department of Public Health, School of Global Health, Meharry Medical College, 1005 Dr. D.B. Todd Jr. Blvd., Nashville, TN 37208-3501, USA.

ORCID-Profile: Mohammad Tabatabai, Derek Wilus, Paul D Juarez

Förderung

  • NHLBI NIH HHS
  • CEO Roundtable on Cancer
  • NIH HHS
  • National Institutes of Health (NIH)

Zitieren

APA

Alcendor, D. J., Matthews-Juarez, P., Tabatabai, M., Wilus, D., Hildreth, J. E. K., & Juarez, P. D. (2025). Improving HPV Vaccine Coverage in Tennessee: Addressing Barriers and Expanding Access for Mid-Adults. Pathogens. https://doi.org/10.3390/pathogens14040311

Vancouver

Alcendor DJ, Matthews-Juarez P, Tabatabai M, Wilus D, Hildreth JEK, Juarez PD. Improving HPV Vaccine Coverage in Tennessee: Addressing Barriers and Expanding Access for Mid-Adults. Pathogens. 2025. doi:10.3390/pathogens14040311

BibTeX
@article{Alcendor2025,
  author = {Alcendor, Donald J and Matthews-Juarez, Patricia and Tabatabai, Mohammad and Wilus, Derek and Hildreth, James E K and Juarez, Paul D},
  title = {Improving HPV Vaccine Coverage in Tennessee: Addressing Barriers and Expanding Access for Mid-Adults},
  journal = {Pathogens},
  year = {2025},
  doi = {10.3390/pathogens14040311}
}
Kostenlos starten →